Kaya Miah

ORCID

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 7

Top Venues

Blood cancer journal

Blood

This page only lists publications with an associated author ORCID identifier.

Publications

Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Nicola Giesen, Manik Chatterjee, Christof Scheid, Alexandra M Poos, Britta Besemer, Kaya Miah, Axel Benner, Nicole Becker, Thomas Moehler, Ivana Metzler, Cyrus Khandanpour, Andrea Seidel-Glaetzer, Karolin Trautmann-Grill, Klaus Martin Kortüm, Carsten Muller-Tidow, Gunhild Mechtersheimer, Benjamin Goeppert, Albrecht Stenzinger, Niels Weinhold, Hartmut Goldschmidt, Katja C Weisel, Marc S Raab
A phase II clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma. Blood (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)
Elias Karl Mai, Stefanie Huhn, Kaya Miah, Alexandra M Poos, Christof Scheid, Katja C Weisel, Uta Bertsch, Markus Munder, Oscar Berlanga, Dirk Hose, Anja Seckinger, Anna Jauch, Igor W Blau, Mathias Hänel, Hans J Salwender, Axel Benner, Marc-Steffen Raab, Hartmut Goldschmidt, Niels Weinhold
Implications and prognostic impact of mass spectrometry in patients with newly-diagnosed multiple myeloma. Blood cancer journal 13 (1) (2023)

Kaya Miah.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Kaya Miah